World’s First and Only Portable PET Scanner Awarded FDA Clearance
By MedImaging International staff writers Posted on 20 Aug 2021 |
Image: BBX-PET scanner (Photo courtesy of Prescient Imaging LLC)
The world’s first and only portable positron emission tomography (PET) scanner has been granted 510k FDA clearance.
The portable PET scanner named BBX-PET from Prescient Imaging LLC (Hawthorne, CA, USA) is the first and only portable PET scanner that is cleared for use by the US Federal Food and Drug Administration. The BBX is a portable PET scanner for imaging of breast, brain, and extremities. Its gantry can move up to allow brain imaging while the patient is seated. It can also move down to image the breast without compression, while a patient is lying on a biopsy table or rotate and allow imaging the breast, hand, or leg in a seated position.
The most important feature of BBX-PET scanners is that they are portable and can be wheeled to the point-of-care in a physician’s office, a hospital room, ER, OR, or nursing homes. Because the organ-specific scanner is approximately 300 lb, it can easily be transported to deliver point-of-care molecular imaging. The logistical advantage of BBX-PET will greatly expand the availability of this vital imaging modality.
“BBX-PET scanner is intended to obtain positron emission tomography (PET) images of parts of the human body that fit in the patient aperture (e.g., head) to detect abnormal patterns of distribution of radioactivity after injection of a positron-emitting radiopharmaceutical. This information can assist in research, diagnosis, therapeutic planning, and therapeutic outcome assessment,” said Dr. Farhad Daghighian, CEO and co-founder of Prescient Imaging LLC. “We expect our scanners provide unparalleled opportunities for growth in neurology, geriatric psychiatry, and radiation oncology centers. In addition, BBX-PET scanners provide higher resolution than conventional PET scanners and at a lower cost.”
“PET imaging of the brain is essential to the accurate diagnosis of Alzheimer’s disease”, according to Michael Rafii MD, Ph.D., Associate Professor of Neurology at the Keck School of Medicine of the University of Southern California. “As new therapeutics become available for the treatment of Alzheimer’s Disease, accurate diagnosis will be critical before initiation of any disease-modifying therapy.”
Related Links:
Prescient Imaging LLC
The portable PET scanner named BBX-PET from Prescient Imaging LLC (Hawthorne, CA, USA) is the first and only portable PET scanner that is cleared for use by the US Federal Food and Drug Administration. The BBX is a portable PET scanner for imaging of breast, brain, and extremities. Its gantry can move up to allow brain imaging while the patient is seated. It can also move down to image the breast without compression, while a patient is lying on a biopsy table or rotate and allow imaging the breast, hand, or leg in a seated position.
The most important feature of BBX-PET scanners is that they are portable and can be wheeled to the point-of-care in a physician’s office, a hospital room, ER, OR, or nursing homes. Because the organ-specific scanner is approximately 300 lb, it can easily be transported to deliver point-of-care molecular imaging. The logistical advantage of BBX-PET will greatly expand the availability of this vital imaging modality.
“BBX-PET scanner is intended to obtain positron emission tomography (PET) images of parts of the human body that fit in the patient aperture (e.g., head) to detect abnormal patterns of distribution of radioactivity after injection of a positron-emitting radiopharmaceutical. This information can assist in research, diagnosis, therapeutic planning, and therapeutic outcome assessment,” said Dr. Farhad Daghighian, CEO and co-founder of Prescient Imaging LLC. “We expect our scanners provide unparalleled opportunities for growth in neurology, geriatric psychiatry, and radiation oncology centers. In addition, BBX-PET scanners provide higher resolution than conventional PET scanners and at a lower cost.”
“PET imaging of the brain is essential to the accurate diagnosis of Alzheimer’s disease”, according to Michael Rafii MD, Ph.D., Associate Professor of Neurology at the Keck School of Medicine of the University of Southern California. “As new therapeutics become available for the treatment of Alzheimer’s Disease, accurate diagnosis will be critical before initiation of any disease-modifying therapy.”
Related Links:
Prescient Imaging LLC
Latest General/Advanced Imaging News
- PET Scans Reveal Hidden Inflammation in Multiple Sclerosis Patients
- Artificial Intelligence Evaluates Cardiovascular Risk from CT Scans
- New AI Method Captures Uncertainty in Medical Images
- CT Coronary Angiography Reduces Need for Invasive Tests to Diagnose Coronary Artery Disease
- Novel Blood Test Could Reduce Need for PET Imaging of Patients with Alzheimer’s
- CT-Based Deep Learning Algorithm Accurately Differentiates Benign From Malignant Vertebral Fractures
- Minimally Invasive Procedure Could Help Patients Avoid Thyroid Surgery
- Self-Driving Mobile C-Arm Reduces Imaging Time during Surgery
- AR Application Turns Medical Scans Into Holograms for Assistance in Surgical Planning
- Imaging Technology Provides Ground-Breaking New Approach for Diagnosing and Treating Bowel Cancer
- CT Coronary Calcium Scoring Predicts Heart Attacks and Strokes
- AI Model Detects 90% of Lymphatic Cancer Cases from PET and CT Images
- Breakthrough Technology Revolutionizes Breast Imaging
- State-Of-The-Art System Enhances Accuracy of Image-Guided Diagnostic and Interventional Procedures
- Catheter-Based Device with New Cardiovascular Imaging Approach Offers Unprecedented View of Dangerous Plaques
- AI Model Draws Maps to Accurately Identify Tumors and Diseases in Medical Images